Last updated on August 2019

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus


Brief description of study

The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).

Clinical Study Identifier: NCT03616912

Find a site near you

Start Over